EHI
CTLT

Eagle Health Investments’s CATALENT, INC. CTLT Stock Holding History

Eagle Health Investments’s Portfolio CTLT Stock Details CTLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-459,621
Closed -$19.9M – 26
2023
Q2 		$19.9M Buy
+459,621
New +$20.2M 3.73% 14
2023
Q1 		– Sell
-329,100
Closed -$14.8M – 30
2022
Q4 		$14.8M Buy
+329,100
New +$17.9M 3.42% 14

Other funds holding CTLT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Eagle Health Investments's CTLT Position: Q3 2023 in Review

Eagle Health Investments sold out of CATALENT, INC. (CTLT) in Q3 2023, closing a stake of 459,621 shares — an estimated $19.9M sold.

Eagle Health Investments first reported a position in CTLT in Q4 2022 and held it in 2 quarters. The position peaked at $19.9M in Q2 2023. 435 funds tracked by Wall St. Rank hold CTLT as of Q3 2023.

  • Eagle Health Investments reported no remaining CATALENT, INC. position as of Q3 2023 after selling out during the quarter.
  • Eagle Health Investments sold 459,621 CATALENT, INC. shares in Q3 2023, an estimated $19.9M.
  • Eagle Health Investments first reported a position in CATALENT, INC. in Q4 2022 and held it in 2 quarters.
  • Eagle Health Investments's CATALENT, INC. position peaked at $19.9M in Q2 2023.
  • 435 funds tracked by Wall St. Rank held CATALENT, INC. as of Q3 2023.

Based on Eagle Health Investments's 13F filing for Q3 2023, filed 27 Oct 2023.